Related Experiment Video
Updated: Apr 9, 2026
08:36
Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner
Published on: June 7, 2024
824
Pediatric microdose and microtracer studies using 14C in Europe
M A Turner1, M G Mooij2, W H J Vaes3
1Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Clinical Pharmacology and Therapeutics
|June 23, 2015
Summary
Pediatric drug studies face challenges, but microdose and microtracer methods using carbon-14 labeled probes offer a promising approach for evaluating drug safety and efficacy in children.
Area of Science:
- Pediatric pharmacology
- Radiopharmaceutical research
Background:
- Significant knowledge gaps exist regarding the safety and efficacy of medications in pediatric populations.
- Ethical, practical, and scientific hurdles complicate pediatric drug development.
- A lack of child-adapted innovative methodologies hinders drug evaluation for children.
Purpose of the Study:
- To present successful European experiences with pediatric microdose and microtracer studies.
- To illustrate the strengths and limitations of these specialized study designs.
Main Methods:
- Utilized carbon-14 (14C)-labeled probes for microdose and microtracer studies in pediatric populations.
- Applied these methodologies within a European research context.
Main Results:
- Demonstrated the successful application of pediatric microdose and microtracer studies.
- Provided insights into the practical strengths and limitations of these approaches in children.
Conclusions:
- Pediatric microdose and microtracer studies using 14C-labeled probes are viable methods for drug evaluation.
- These approaches offer valuable data on drug efficacy and safety in pediatric populations despite existing challenges.
